Literature DB >> 8175160

Human insulin-mediated enhancement of vascular beta-adrenergic responsiveness.

R Gros1, K R Borkowski, R D Feldman.   

Abstract

Insulin may play an important role in the physiological and/or pathophysiological regulation of the cardiovascular system. Defects in insulin secretion and insulin receptor responsiveness have been associated with increased peripheral resistance and hypertension. The mechanisms linking these events remain unclear. To assess the effect of insulin on beta-adrenergic-mediated vasodilation, we examined aortic ring segments obtained from normotensive male Wistar and spontaneously hypertensive rats. Vessels were maximally preconstricted with phenylephrine (3 mumol/L). Relaxation was induced by either isoproterenol (10 mumol/L) or sodium nitroprusside (10 nmol/L), and the relaxant response was followed for 20 minutes. Insulin exposure did not alter phenylephrine-mediated constriction. However, insulin mediated a dose-dependent increase in isoproterenol-induced relaxation, to a maximum of 120 +/- 4% of baseline isoproterenol-mediated relaxation, with an EC50 for insulin of 32 pmol/L in aortic rings from Wistar rats. Insulin exposure also did not alter nitroprusside-mediated relaxation. In contrast to the results obtained in rings from Wistar rats, insulin did not enhance isoproterenol-mediated responses in rings from spontaneously hypertensive rats. Thus, insulin mediates a selective enhancement of vascular beta-adrenergic responsiveness in aortas from normotensive but not hypertensive animals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8175160     DOI: 10.1161/01.hyp.23.5.551

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  Hypertension in diabetes: the role of the vasculature.

Authors:  Naftali Stern; Yonit Marcus
Journal:  Curr Hypertens Rep       Date:  2004-04       Impact factor: 5.369

2.  Insulin modulation of an endothelial nitric oxide component present in the alpha2- and beta-adrenergic responses in human forearm.

Authors:  G Lembo; G Iaccarino; C Vecchione; E Barbato; R Izzo; D Fontana; B Trimarco
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

3.  Sympathetically mediated increases in cardiac output, not restraint of peripheral vasodilation, contribute to blood pressure maintenance during hyperinsulinemia.

Authors:  Jacqueline K Limberg; James A Smith; Rogerio N Soares; Jennifer L Harper; Keeley N Houghton; Dain W Jacob; Michael T Mozer; Zachary I Grunewald; Blair D Johnson; Timothy B Curry; Tracy Baynard; Camila Manrique-Acevedo; Jaume Padilla
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-06-05       Impact factor: 4.733

4.  Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: dependence on cyclic guanosine monophosphate and modulation of catecholamine effects.

Authors:  M Trovati; P Massucco; L Mattiello; F Cavalot; E M Mularoni; A W Hahn; G Anfossi
Journal:  Diabetologia       Date:  1996-10       Impact factor: 10.122

5.  Effects of L-canavanine and ozone on vascular reactivity in septicemic rats.

Authors:  Mohamed A Haidara; Mohamed D Morsy; Hesham A Abdel-Razek; Dimitri P Mikhailidis; Esma R Isenovic
Journal:  J Physiol Biochem       Date:  2010-07-22       Impact factor: 4.158

Review 6.  Role of the Autonomic Nervous System in the Hemodynamic Response to Hyperinsulinemia-Implications for Obesity and Insulin Resistance.

Authors:  Jacqueline K Limberg; Rogerio N Soares; Jaume Padilla
Journal:  Curr Diab Rep       Date:  2022-03-05       Impact factor: 4.810

7.  Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone.

Authors:  M Trovati; P Massucco; L Mattiello; F Cavalot; E Mularoni; A Hahn; G Anfossi
Journal:  Diabetologia       Date:  1995-08       Impact factor: 10.122

8.  Changes in aortic reactivity associated with the loss of equilibrative nucleoside transporter 1 (ENT1) in mice.

Authors:  K Arielle Best; Derek B Bone; Gonzalo Vilas; Robert Gros; James R Hammond
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.